ariad pharmaceuticals inc
David Baltimore Ph.D.
Scientific Founder and Consultant, Ariad Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 118 board members in 8 different organizations across 9 different industries.|
See Board Relationships
Dr. David Baltimore, Ph.D. is the Co-Founder and Chairman of Calimmune, Inc. Dr. Baltimore founded Immune Design Corp. He serves as a Scientific Advisor to a number of leading companies in the biotechnology field. He has been a Robert Andrews Millikan Professor of Biology of California Institute of Technology since October 1997. He is a Science Partner of The Column Group LLC. He was previously a Member of Advisory Board at the firm. He is a Scientific Founder and Consultant ...
26 Landsdowne StreetPhone: 617-494-0400
Cambridge, Massachusetts 02139
Board Members Memberships*
Trustee and President
Former Vice Chairman
Director, Member of Audit Committee and Member of Governance & Nominating Committee
Director, Member of Investment Committee and Member of Compliance Committee
Director, Member of Scientific Advisory Board and Chairman of Nominating & Corporate Governance Committee
Chairman of The Scientific Advisory Board, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Massachusetts Institute of Technology
Mount Holyoke College
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jack Lief Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Arena Pharmaceuticals, Inc.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|Werner Lanthaler MBA,MPA||Chief Executive Officer and Member of Management Board|
|Aijaz Tobaccowalla||Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee|
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$1.0M||Compensation as of Fiscal Year 2013.|